ClinicalTrials.gg
CompletedNCT02760095ZEED1Updated Jul 1, 2019

Effects of EED on Zn Absorption and Retention in Children From a Standard Dose

An observational study in Environmental Enteric Dysfunction, Zinc Deficiency and Vitamin A Deficiency, sponsored by University of Colorado, Denver. Completed at 2 sites in 2 countries. Open to participants aged 18 Months to 24 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-01.

Sponsored by University of Colorado, Denver · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
46
Ages
18 Months to 24 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 16 studies in Vitamin A Deficiency with a site in United States — 5 open to participants now, 6 under way, 1 of them phase 3. Vitamin A Deficiency · United States.

Started
2015
with 1 other
Observational
4 of 16
none open now
Registered
6th of 16
by date
Lead sponsor
1 of 16
University of Colorado, Denver

Among the 16 studies in Vitamin A Deficiency with a site in United States, this one is one of 2 that started in 2015, is one of 4 observational ones, and was the 6th registered.

Vitamin A Deficiency

67 studies on the registry are indexed under Vitamin A Deficiency; 7 are open to participants now.

Browse Vitamin A Deficiency studies →

Open to participants now

5 of the 16 studies in Vitamin A Deficiency with a site in United States are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 6 Vitamin A Deficiency studies recruiting now, 3 set no upper age limit and 3 stop at 75 or younger; 2 take children under 18; 2 take healthy volunteers.

This study: 18 Months to 24 Months · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Vitamin A Deficiency with a site in United States, or all of them as a file.
02

Study summary

The overall objective is to determine the impact of EED on zinc absorption and homeostasis, and its impact on the absorptive capacity of vitamin A absorption of young children (18-24 months of age) in an austere setting with high rates of diarrhea, stunting, and micro-nutrient deficiencies.

Read the detailed description

Participating children are screened for EED using the lactulose:mannitol ratio test and assigned to one of two groups: +EED or -EED. All participants will be given standard, physiological dose of 3 mg zinc sulfate with a zinc stable isotope tracer on study day 8.

On study day 11, 0.5 mg of 13C10-retinyl-acetate will be administered orally to all participants.

Spot urine samples will be collected twice daily from study days 11-14. Complete fecal collections will be obtained for days 11-14. Duplicate diets of all foods consumed will be collected on days 11-14. On study day 14, a blood sample will be taken for analysis of vitamin A isotope status.

03

Conditions studied

  • Environmental Enteric Dysfunction
  • Zinc Deficiency
  • Vitamin A Deficiency

Browse trials for

Keywords

  • environmental enteric dysfunction
  • environmental enteropathy
  • zinc
  • vitamin A
  • Bangladesh
04

Who can participate

Ages eligible
18 Months to 24 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Toddlers aged 18-24 mos living in Dhaka, Bangladesh

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Absence of apparent health problems that would impair ability to consume regular diet, to tolerate zinc supplements, or to comply with demands of metabolic studies
  • Length for age Z-score (LAZ) between -1.5 to -3.0
  • (Hgb) ≥ 8

Exclusion criteria

Exclusion Criteria:

  • Outside age range
  • \< 8
  • Chronic illness
  • Recent diarrhea (within past 2 weeks, treated with supplemental zinc)
  • Severe stunting and/or severe acute malnutrition (SAM): LAZ \<-3; Weight-for-age Z-score (WHZ) \<-3 or mid-upper arm circumference (MUAC) \< 115 or edema
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
46 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Children with EED

    Children are placed in this arm if they screen positive for EED using the urinary lactulose:mannitol (L:M) recovery ratio. Children will receive a one-time 3 mg standard dose of zinc sulfate with stable isotope zinc tracer and 0.5 mg standard dose of 13C10-retinyl-acetate (vitamin A isotope).

    Drug: 3 mg zinc sulfate supplement · Drug: 0.5 mg of 13C10-retinyl-acetate

  • Children without EED

    Children are placed in this arm if they screen negative for EED using the urinary lactulose:mannitol (L:M) recovery ratio. Children will receive a one-time 3 mg standard dose of zinc sulfate with stable isotope zinc tracer and 0.5 mg standard dose of 13C10-retinyl-acetate (vitamin A isotope).

    Drug: 3 mg zinc sulfate supplement · Drug: 0.5 mg of 13C10-retinyl-acetate

Interventions

  • Drug3 mg zinc sulfate supplement
  • Drug0.5 mg of 13C10-retinyl-acetate

    Also known as: Vitamin A isotope

06

What researchers measure

Primary outcomes

  1. Absorption of zinc (AZ) from standard dose

    Absorption of zinc from standard 3 mg dose will be measured using zinc isotope tracer methods

    Time frame: 1 day

  2. Endogenous fecal zinc (EFZ)

    EFZ measured from zinc isotope ratios in complete fecal collections

    Time frame: 4 days

  3. Vitamin A absorption

    Absorption efficiency of retinol will be measured by isotope ratios in blood

    Time frame: 1 day

Secondary outcomes

  1. Plasma zinc

    Plasma zinc concentration

    Time frame: 1 day

  2. Alkaline phosphatase

    Time frame: 1 day

  3. Serum retinol

    Time frame: 1 day

  4. Methyl malonic acid

    serum

    Time frame: 1 day

  5. Vitamin B12

    Time frame: 1 day

  6. Serum ferritin

    Time frame: 1 day

  7. Soluble transferrin receptors

    Time frame: 1 day

  8. C-reactive Protein (CRP)

    Time frame: 1 day

  9. Alpha-Glycoprotein (AGP)

    Time frame: 1 day

  10. Tumor necrosis factor (TNF) alpha

    Time frame: 1 day

  11. Serum endocab

    Time frame: 1 day

  12. Fecal neopterin

    Time frame: 1 day

  13. Myeloperoxidase

    Time frame: 1 day

  14. Alpha 1 antitrypsin

    Time frame: 1 day

  15. Calprotectin

    Time frame: 1 day

07

Study locations

2 sites
  • University of Colorado Denver School of Medicine
    Aurora, Colorado 80045, United States
  • icddr,b (International Centre for Diarrheal Disease Research, Bangladesh
    Dhaka, Bangladesh
08

References and documents

Publications

  • Mondal P, Long JM, Westcott JE, Islam MM, Ahmed M, Mahfuz M, Ahmed T, Miller LV, Krebs NF. Zinc Absorption and Endogenous Fecal Zinc Losses in Bangladeshi Toddlers at Risk for Environmental Enteric Dysfunction. J Pediatr Gastroenterol Nutr. 2019 Jun;68(6):874-879. doi: 10.1097/MPG.0000000000002361. PubMed 31033623 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2015 to primary completion in Jun 2017, 19 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2015
First posted
May 3, 2016
StartActual
Nov 2015
Primary completionActual
Jun 2017
CompletionActual
Jun 2017
Last update
Jul 1, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02760095
Responsible party
Sponsor
First posted
May 3, 2016
Start date
Nov 2015
Primary completion
Jun 2017
Completion
Jun 2017
Last update
Jul 1, 2019

Study contacts

Nancy F Krebs, MD, MS
principal investigator · University of Colorado, Denver

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion